Day: March 6, 2024

Chronic obstructive pulmonary disease (COPD) looms as a $10 billion healthcare crisis in Canada by 2030 and, according to the Lung Health Foundation (“LHF”), is poised to dismantle the Canadian healthcare system. LHF is the nation’s leading non-profit organization dedicated to supporting and empowering individuals living with lung conditions across Canada.

In February 2024, Pfizer joins forces with the Lung Health Foundation (LHF), Lung Cancer Canada (LCC), and the Quebec Lung Association (QLA) to spearhead a groundbreaking initiative. This collaborative effort aims to revolutionize the care and outcomes for Canadians battling metastatic non-small cell lung cancer (NSCLC), with a pivotal focus on enhancing health equity within this community.